Background

Understanding the level and characteristics of protection from past SARS-CoV-2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe disease is essential for predicting future potential disease burden, for designing policies that restrict travel or access to venues where there is a high risk of transmission, and for informing choices about when to receive vaccine doses. We aimed to systematically synthesise studies to estimate protection from past infection by variant, and where data allow, by time since infection.

Interpretation

Protection from past infection against re-infection from pre-omicron variants was very high and remained high even after 40 weeks. Protection was substantially lower for the omicron BA.1 variant and declined more rapidly over time than protection against previous variants. Protection from severe disease was high for all variants. The immunity conferred by past infection should be weighed alongside protection from vaccination when assessing future disease burden from COVID-19, providing guidance on when individuals should be vaccinated, and designing policies that mandate vaccination for workers or restrict access, on the basis of immune status, to settings where the risk of transmission is high, such as travel and high-occupancy indoor settings.

👀

  • JoeByeThen [he/him, they/them]
    ·
    edit-2
    1 year ago

    Funding

    Bill & Melinda Gates Foundation, J Stanton, T Gillespie, and J and E Nordstrom.

    Edit: Caroline Stein is with IMHE, one of the labs that has been making notoriously bad predictions since the beginning. See this post and my comments on it. Imhe is one of the groups that politicians in DC use to manufacture consent around the ignoring the pandemic and should taken very cautiously.